4
Changes in Ownership
NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001596771-19-000134
Options or other derivatives
- CEO and President acquired 500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Rosa David A · CEO and President
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-11-05 | Grant or award : show line 1 in the form Option to Purchase Common Stock | +500,000 | $2.14 | 2029-11-05 | 500,000 | 500,000 | D |
Loading xslF345X03/primary_doc.xml…